Patent · US Active

Biological materials related to CXCR7

US9758584B2 · kind B2 · utility

0Cited by

2References

20Claims

0Family size

Assignee

Ablynx N.V. · BE

Inventors

Francis Descamps · Roeselare, BE
Maria Gonzalez · Port St. Lucie, US
Pascal MERCHIERS · Kasterlee, BE
Catelijne Stortelers · Evergem, BE
Peter Vanlandschoot · Bellem, BE
Philippe Van Rompaey · Melle, BE
Martine Smit · Amsterdam, NL
Regorius Leurs · Amsterdam, NL
David Andre Baptiste Maussang-Detaille · Rotterdam, NL

Key dates

Filing date	Sep 30, 2014
Grant date	Sep 12, 2017
Priority date	—
Expiry date	Oct 15, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to particular polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to host cells expressing or capable of expressing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.